Compartir
Heparin-Induced Thrombocytopenia, Fifth Edition (en Inglés)
Warkentin, Theodore E. ; Greinacher, Andreas (Autor)
·
CRC Press
· Tapa Dura
Heparin-Induced Thrombocytopenia, Fifth Edition (en Inglés) - Warkentin, Theodore E. ; Greinacher, Andreas
$ 264.61
$ 407.10
Ahorras: $ 142.48
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 29 de Mayo y el
Lunes 10 de Junio.
Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Heparin-Induced Thrombocytopenia, Fifth Edition (en Inglés)"
Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies--including the use of alternative anticoagulants to manage critical circumstances--this is an essential resource for all clinicians and a "must" for hematology consultants. Heparin-Induced Thrombocytopenia, Fifth Edition explores: Clinical and laboratory studies on HIT The immune basis and pathogenesis, animal models, and laboratory testing for HIT antibodies Clinical features, differential diagnosis, scoring systems, and frequency of HIT in diverse clinical settings, including pediatric patients Evidence-based guidelines for recognition, treatment, and prevention Actions that should and should not be taken after the identification of HIT Traditional and novel pharmacotherapies, current dosing guidelines, and the advantages and limitations of alternative anticoagulants Selection criteria from a variety of new treatment options, helping physicians determine which of these agents are safe and effective for their patients
